Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
Lechowicz MJ, Lazarus HM, Carreras J, Laport GG, Cutler CS, Wiernik PH, Hale GA, Maharaj D, Gale RP, Rowlings PA, Freytes CO, Miller AM, Vose JM, Maziarz RT, Montoto S, Maloney DG, Hari PN. Lechowicz MJ, et al. Bone Marrow Transplant. 2014 Nov;49(11):1360-5. doi: 10.1038/bmt.2014.161. Epub 2014 Jul 28. Bone Marrow Transplant. 2014. PMID: 25068422 Free PMC article.
A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma.
Kaufman JL, Flowers CR, Rados KD, Calandra GB, Vose JM, Hewes LB, Lonial S, Langston AA, Khoury HJ, Lechowicz MJ, Waller EK. Kaufman JL, et al. Among authors: lechowicz mj. Transfusion. 2013 Jan;53(1):76-84. doi: 10.1111/j.1537-2995.2012.03719.x. Epub 2012 May 25. Transfusion. 2013. PMID: 22624594
Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S, Akhtari M, Kaufman J, Torre C, Lechowicz MJ, Flowers C, Sinha R, Khoury HJ, Langston AA, Waller EK. Lonial S, et al. Among authors: lechowicz mj. Biol Blood Marrow Transplant. 2013 Mar;19(3):460-7. doi: 10.1016/j.bbmt.2012.11.017. Epub 2012 Nov 28. Biol Blood Marrow Transplant. 2013. PMID: 23201472 Free article. Clinical Trial.
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
Harvey RD, Kaufman JL, Johnson HR, Nooka A, Vaughn L, Flowers CR, Khoury HJ, Lechowicz MJ, Langston AA, Lonial S, Waller EK. Harvey RD, et al. Among authors: lechowicz mj. Biol Blood Marrow Transplant. 2013 Sep;19(9):1393-5. doi: 10.1016/j.bbmt.2013.06.003. Epub 2013 Jun 10. Biol Blood Marrow Transplant. 2013. PMID: 23764455 Free article. Clinical Trial.
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
Langston AA, Prichard JM, Muppidi S, Nooka A, Lechowicz MJ, Lonial S, Sinha R, Graiser M, Kaufman JL, Khoury HJ, Flowers CR, Waller EK. Langston AA, et al. Among authors: lechowicz mj. Bone Marrow Transplant. 2014 Feb;49(2):185-9. doi: 10.1038/bmt.2013.168. Epub 2013 Oct 28. Bone Marrow Transplant. 2014. PMID: 24162613
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Advani RH, Ansell SM, Lechowicz MJ, Beaven AW, Loberiza F, Carson KR, Evens AM, Foss F, Horwitz S, Pro B, Pinter-Brown LC, Smith SM, Shustov AR, Savage KJ, Vose JM. Advani RH, et al. Among authors: lechowicz mj. Br J Haematol. 2016 Feb;172(4):535-44. doi: 10.1111/bjh.13855. Epub 2015 Dec 2. Br J Haematol. 2016. PMID: 26627450 Free PMC article. Clinical Trial.
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
DeFilipp Z, Rosand CB, Goldstein DA, Master VA, Carthon BC, Harris WB, Kucuk O, Al-Kadhimi Z, Cohen JB, Flowers CR, Lechowicz MJ, Nooka AK, Kaufman JL, Langston AA, Chen Z, Arora J, Waller EK. DeFilipp Z, et al. Among authors: lechowicz mj. Bone Marrow Transplant. 2017 Jan;52(1):132-134. doi: 10.1038/bmt.2016.189. Epub 2016 Jul 18. Bone Marrow Transplant. 2017. PMID: 27427922 No abstract available.
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.
Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network. Federico M, et al. Among authors: lechowicz mj. Br J Haematol. 2018 Jun;181(6):760-769. doi: 10.1111/bjh.15258. Epub 2018 Apr 19. Br J Haematol. 2018. PMID: 29672827 Free PMC article. Clinical Trial.
130 results